IL-4	B-protein
-dependent	O
regulation	O
of	O
TGF-alpha	O
and	O
TGF-beta1	O
expression	O
in	O
human	B-cell_type
eosinophils	I-cell_type
.	O

TGFs	B-protein
play	O
important	O
roles	O
in	O
wound	O
healing	O
and	O
carcinogenesis	O
.	O

We	O
have	O
previously	O
demonstrated	O
that	O
eosinophils	B-cell_type
infiltrating	O
into	O
different	O
pathologic	O
processes	O
elaborate	O
TGF-alpha	B-protein
and	O
TGF-beta1	B-protein
.	O

Eosinophils	B-cell_type
infiltrating	O
hamster	O
cutaneous	O
wounds	O
were	O
found	O
to	O
express	O
TGFs	B-protein
sequentially	O
.	O

In	O
this	O
study	O
,	O
we	O
examined	O
the	O
biologic	O
mediators	O
that	O
may	O
regulate	O
the	O
expression	O
of	O
TGF-alpha	B-protein
and	I-protein
-beta1	I-protein
by	O
eosinophils	B-cell_type
.	O

Eosinophils	B-cell_type
were	O
isolated	O
from	O
the	O
peripheral	O
blood	O
of	O
healthy	O
donors	O
and	O
cultured	O
in	O
the	O
absence	O
or	O
presence	O
of	O
IL-3	B-protein
,	O
IL-4	B-protein
,	O
and	O
IL-5	B-protein
.	O

Cells	O
were	O
analyzed	O
by	O
in	O
situ	O
hybridization	O
and	O
immunohistochemistry	O
.	O

Supernatants	O
from	O
these	O
cultures	O
were	O
assayed	O
for	O
secreted	O
TGF-alpha	B-protein
and	O
TGF-beta1	B-protein
using	O
TGF	B-protein
-specific	O
ELISAs	O
.	O

IL-3	B-protein
,	O
IL-4	B-protein
,	O
and	O
IL-5	B-protein
independently	O
up-regulated	O
TGF-beta1	B-RNA
mRNA	I-RNA
and	O
product	O
expression	O
by	O
eosinophils	B-cell_type
in	O
all	O
donors	O
.	O

Interestingly	O
,	O
TGF-alpha	B-protein
production	O
by	O
eosinophils	B-cell_type
was	O
up-regulated	O
by	O
IL-3	B-protein
and	O
IL-5	B-protein
but	O
was	O
down-regulated	O
by	O
IL-4	B-protein
.	O

Consistent	O
with	O
the	O
ability	O
of	O
IL-4	B-protein
to	O
regulate	O
eosinophil	O
responses	O
,	O
IL-4	B-protein
signaling	I-protein
molecules	I-protein
are	O
present	O
in	O
human	B-cell_type
eosinophils	I-cell_type
.	O

The	O
observation	O
that	O
IL-4	B-protein
can	O
differentially	O
regulate	O
the	O
expression	O
of	O
TGF-alpha	B-protein
and	O
TGF-beta1	B-protein
suggests	O
that	O
IL-4	B-protein
may	O
serve	O
as	O
a	O
physiologic	O
molecular	O
switch	O
of	O
TGF	B-protein
expression	O
by	O
the	O
infiltrating	O
eosinophils	B-cell_type
in	O
wound	O
healing	O
and	O
carcinogenesis	O
.	O

x	NULL
Boldly	NULL
GolnVivo	NULL
``	NULL
``	NULL
BioLegend®	NULL
#	NULL
s	NULL
meJournal	NULL
o	NULL
IL-4-Dependent	NULL
Regulation	NULL
of	NULL
TGF-	NULL
and	NULL
TGF-B	NULL
'D	NULL
Immunolo	NULL
gy	NULL
1	NULL
Expression	NULL
in	NULL
Human	NULL
Eosinophils	NULL
Aram	NULL
E.	NULL
Elovic	NULL
,	NULL
Hiroe	NULL
Ohyama	NULL
,	NULL
Alan	NULL
Sauty	NULL
,	NULL
Jim	NULL
McBride	NULL
,	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Wong	NULL
J	NULL
Immunol	NULL
1998	NULL
;	NULL
160:6121-6127	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/160/12/6121	NULL
Takanori	NULL
Tsuji	NULL
,	NULL
Masazumi	NULL
Nagai	NULL
,	NULL
Peter	NULL
F.	NULL
Weller	NULL
and	NULL
David	NULL
T.	NULL
W.	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
24	NULL
articles	NULL
,	NULL
10	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/160/12/6121	NULL
.	NULL

full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
IL-4-Dependent	NULL
Regulation	NULL
of	NULL
TGF-a	NULL
«	NULL
and	NULL
TGF-B1	NULL
Expression	NULL
in	NULL
Human	NULL
Eosinophils	NULL
!	NULL

Aram	NULL
E.	NULL
Elovic	NULL
,	NULL
*	NULL
Hiroe	NULL
Ohyama	NULL
,	NULL
*	NULL
Alan	NULL
Sauty	NULL
,	NULL
'	NULL
``	NULL
Jim	NULL
McBride	NULL
,	NULL
*	NULL
Takanori	NULL
Tsuji	NULL
,	NULL
*	NULL
Masazumi	NULL
Nagai	NULL
,	NULL
*	NULL
Peter	NULL
F.	NULL
Weller	NULL
,	NULL
``	NULL
and	NULL
David	NULL
T.	NULL
W.	NULL
Wong**	NULL
TGFs	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
wound	NULL
healing	NULL
and	NULL
carcinogenesis	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
demonstrated	NULL
that	NULL
eosinophils	NULL
infiltrating	NULL
into	NULL
different	NULL
pathologic	NULL
processes	NULL
elaborate	NULL
TGF-	NULL
«	NULL
and	NULL
TGF-B1	NULL
.	NULL

Eosinophils	NULL
infiltrating	NULL
hamster	NULL
cutaneous	NULL
wounds	NULL
were	NULL
found	NULL
to	NULL
express	NULL
TGFs	NULL
sequentially	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
biologic	NULL
mediators	NULL
that	NULL
may	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
TGF-a	NULL
@	NULL
and	NULL
-1	NULL
by	NULL
eosinophils	NULL
.	NULL

Eosinophils	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
healthy	NULL
donors	NULL
and	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IL-5	NULL
.	NULL

Cells	NULL
were	NULL
analyzed	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
and	NULL
immunohistochemistry	NULL
.	NULL

Supernatants	NULL
from	NULL
these	NULL
cultures	NULL
were	NULL
assayed	NULL
for	NULL
secreted	NULL
TGF-a	NULL
and	NULL
TGF-B1	NULL
using	NULL
TGF-specific	NULL
ELISAs	NULL
.	NULL

IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IL-5	NULL
independently	NULL
up-regulated	NULL
TGF-B1	NULL
mRNA	NULL
and	NULL
product	NULL
expression	NULL
by	NULL
eosinophils	NULL
in	NULL
all	NULL
donors	NULL
.	NULL

Interestingly	NULL
,	NULL
TGF-a	NULL
production	NULL
by	NULL
eosinophils	NULL
was	NULL
up-regulated	NULL
by	NULL
IL-3	NULL
and	NULL
IL-5	NULL
but	NULL
was	NULL
down-regulated	NULL
by	NULL
IL-4	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
IL-4	NULL
to	NULL
regulate	NULL
eosinophil	NULL
responses	NULL
,	NULL
IL-4	NULL
signaling	NULL
molecules	NULL
are	NULL
present	NULL
in	NULL
human	NULL
eosinophils	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
IL-4	NULL
can	NULL
differentially	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
TGF-a	NULL
and	NULL
TGF-B1	NULL
suggests	NULL
that	NULL
IL-4	NULL
may	NULL
serve	NULL
as	NULL
a	NULL
physiologic	NULL
molecular	NULL
switch	NULL
of	NULL
TGF	NULL
expression	NULL
by	NULL
the	NULL
infiltrating	NULL
eosin-	NULL
ophils	NULL
in	NULL
wound	NULL
healing	NULL
and	NULL
carcinogenesis	NULL
.	NULL

-	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1998	NULL
,	NULL
160	NULL
:	NULL
6121-6127.	NULL
osinophils	NULL
are	NULL
bone	NULL
marrow-derived	NULL
granulocytes	NULL
and	NULL
are	NULL
predominantly	NULL
tissue-dwelling	NULL
cells	NULL
.	NULL

They	NULL
are	NULL
activated	NULL
by	NULL
a	NULL
range	NULL
of	NULL
mostly	NULL
T	NULL
cell-derived	NULL
factors	NULL
that	NULL
,	NULL
among	NULL
other	NULL
functions	NULL
,	NULL
can	NULL
stimulate	NULL
eosinophils	NULL
to	NULL
secrete	NULL
their	NULL
stored	NULL
granule	NULL
contents	NULL
and	NULL
increase	NULL
their	NULL
longevity	NULL
in	NULL
tissues	NULL
.	NULL

Although	NULL
it	NULL
has	NULL
recently	NULL
been	NULL
demonstrated	NULL
that	NULL
eosinophils	NULL
can	NULL
express	NULL
and	NULL
elaborate	NULL
many	NULL
different	NULL
cytokines	NULL
,	NULL
their	NULL
roles	NULL
in	NULL
normal	NULL
physiology	NULL
as	NULL
well	NULL
as	NULL
in	NULL
eosinophil-associated	NULL
disease	NULL
processes	NULL
remain	NULL
uncertain	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
that	NULL
eosinophils	NULL
in	NULL
oral	NULL
carcinomas	NULL
can	NULL
synthesize	NULL
TGF-a	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

We	NULL
also	NULL
showed	NULL
that	NULL
eosinophils	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
patients	NULL
with	NULL
idiopathic	NULL
hypereosinophilic	NULL
syndrome	NULL
produce	NULL
TGF-a	NULL
@	NULL
as	NULL
well	NULL
as	NULL
TGF-B1	NULL
,	NULL
whereas	NULL
eosinophils	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
healthy	NULL
donors	NULL
contain	NULL
little	NULL
or	NULL
no	NULL
detectable	NULL
TGFs	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

We	NULL
have	NULL
further	NULL
shown	NULL
that	NULL
eosinophils	NULL
infiltrating	NULL
hamster	NULL
cutaneous	NULL
wounds	NULL
express	NULL
TGFs	NULL
sequentially	NULL
;	NULL
eosinophils	NULL
express	NULL
TGF-	NULL
«	NULL
in	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
wound	NULL
healing	NULL
,	NULL
while	NULL
eosinophil-derived	NULL
TGF-B1	NULL
is	NULL
more	NULL
pronounced	NULL
during	NULL
the	NULL
postacute	NULL
phase	NULL
of	NULL
this	NULL
process	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
conceivable	NULL
that	NULL
specific	NULL
mediators	NULL
released	NULL
within	NULL
the	NULL
microenvironment	NULL
of	NULL
normal	NULL
and	NULL
diseased	NULL
tissues	NULL
can	NULL
regulate	NULL
the	NULL
production	NULL
of	NULL
TGFs	NULL
by	NULL
eosinophils	NULL
.	NULL

*Division	NULL
of	NULL
Oral	NULL
Pathology	NULL
,	NULL
Department	NULL
of	NULL
Oral	NULL
Medicine	NULL
and	NULL
Diagnostic	NULL
Sciences	NULL
,	NULL
Harvard	NULL
School	NULL
of	NULL
Dental	NULL
Medicine	NULL
,	NULL
and	NULL
*Department	NULL
of	NULL
Medicine	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
MA	NULL
02215	NULL
;	NULL
and	NULL
*Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Iwate	NULL
Medical	NULL
University	NULL
School	NULL
of	NULL
Dentistry	NULL
,	NULL
Iwate	NULL
,	NULL
Japan	NULL
Received	NULL
for	NULL
publication	NULL
February	NULL
7	NULL
,	NULL
1996	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
December	NULL
11	NULL
,	NULL
1997	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
DE-10335	NULL
and	NULL
DEO8680	NULL
to	NULL
D.T.W.W	NULL
.	NULL

and	NULL
HL-46563	NULL
and	NULL
Al-20241	NULL
to	NULL
P.F.W	NULL
.	NULL

;	NULL
a	NULL
Physician	NULL
Scientist	NULL
Award	NULL
DB-00323	NULL
to	NULL
A.E	NULL
.	NULL

;	NULL
and	NULL
a	NULL
Research	NULL
Career	NULL
Development	NULL
Award	NULL
DE-00318	NULL
to	NULL
DT.W.W	NULL
.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
D.	NULL
T.	NULL
W.	NULL
Wong	NULL
,	NULL
Division	NULL
of	NULL
Oral	NULL
Pathology	NULL
,	NULL
Department	NULL
of	NULL
Oral	NULL
Medicine	NULL
and	NULL
Diagnostic	NULL
Sciences	NULL
,	NULL
Harvard	NULL
School	NULL
of	NULL
Dental	NULL
Medicine	NULL
,	NULL
188	NULL
Longwood	NULL
Avenue	NULL
,	NULL
Boston	NULL
MA	NULL
02115	NULL
.	NULL

Copyright	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
TGFs	NULL
are	NULL
multifunctional	NULL
cytokines	NULL
with	NULL
various	NULL
biologic	NULL
and	NULL
pathologic	NULL
actions	NULL
,	NULL
such	NULL
as	NULL
stimulatory	NULL
and	NULL
inhibitory	NULL
effects	NULL
on	NULL
epithelial	NULL
cell	NULL
growth	NULL
,	NULL
induction	NULL
of	NULL
angiogenesis	NULL
,	NULL
extracellular	NULL
matrix	NULL
remodeling	NULL
,	NULL
and	NULL
regulation	NULL
of	NULL
inflammatory	NULL
processes	NULL
(	NULL
5-8	NULL
)	NULL
.	NULL

TGF	NULL
production	NULL
by	NULL
eosinophils	NULL
,	NULL
therefore	NULL
,	NULL
may	NULL
be	NULL
important	NULL
in	NULL
carcinogenesis	NULL
as	NULL
well	NULL
as	NULL
inflammatory	NULL
disorders	NULL
and	NULL
wound	NULL
heal-ing	NULL
.	NULL

The	NULL
ability	NULL
to	NULL
control	NULL
TGF	NULL
production	NULL
by	NULL
eosinophils	NULL
may	NULL
therefore	NULL
have	NULL
therapeutic	NULL
benefits	NULL
.	NULL

However	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
mechanisms	NULL
that	NULL
activate	NULL
and	NULL
regulate	NULL
the	NULL
production	NULL
of	NULL
TGFs	NULL
by	NULL
eosinophils	NULL
.	NULL

The	NULL
present	NULL
study	NULL
demonstrates	NULL
that	NULL
the	NULL
basal	NULL
level	NULL
of	NULL
TGF	NULL
expression	NULL
by	NULL
peripheral	NULL
blood	NULL
eosinophils	NULL
can	NULL
be	NULL
enhanced	NULL
by	NULL
IL-3	NULL
and	NULL
IL-5	NULL
.	NULL

Even	NULL
more	NULL
interesting	NULL
is	NULL
the	NULL
finding	NULL
that	NULL
IL-4	NULL
can	NULL
inhibit	NULL
the	NULL
synthesis	NULL
of	NULL
TGF-a	NULL
and	NULL
concurrently	NULL
up-regulate	NULL
the	NULL
synthesis	NULL
of	NULL
TGE-B1	NULL
by	NULL
peripheral	NULL
blood	NULL
eosinophils	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Subjects	NULL
Blood	NULL
(	NULL
200	NULL
ml	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
healthy	NULL
volunteers	NULL
(	NULL
28-34	NULL
years	NULL
old	NULL
)	NULL
.	NULL

These	NULL
subjects	NULL
had	NULL
no	NULL
evidence	NULL
by	NULL
history	NULL
and	NULL
physical	NULL
examination	NULL
of	NULL
asthma	NULL
or	NULL
other	NULL
allergic	NULL
diseases	NULL
.	NULL

Human	NULL
eosinophil	NULL
isolation	NULL
Eosinophils	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
six	NULL
healthy	NULL
donors	NULL
.	NULL

Whole	NULL
blood	NULL
was	NULL
subjected	NULL
to	NULL
dextran	NULL
sedimentation	NULL
(	NULL
Macrodex	NULL
,	NULL
Pharma-cia	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
,	NULL
centrifugation	NULL
through	NULL
Ficoll-Paque	NULL
(	NULL
Pharmacia	NULL
)	NULL
,	NULL
and	NULL
hypotonic	NULL
lysis	NULL
of	NULL
erythrocytes	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Eosinophils	NULL
were	NULL
enriched	NULL
from	NULL
granulocytes	NULL
and	NULL
passage	NULL
via	NULL
the	NULL
MACS	NULL
system	NULL
by	NULL
sequential	NULL
incubation	NULL
at	NULL
4°C	NULL
with	NULL
anti-CD16	NULL
mAb	NULL
magnetic	NULL
beads	NULL
(	NULL
Mil-tenyi	NULL
Biotec	NULL
,	NULL
Auburn	NULL
,	NULL
CA	NULL
)	NULL
to	NULL
deplete	NULL
CD16	NULL
*	NULL
neutrophils	NULL
as	NULL
described	NULL
by	NULL
Lim	NULL
and	NULL
Weller	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Cytokine	NULL
treatments	NULL
Eosinophils	NULL
with	NULL
purities	NULL
of	NULL
95	NULL
to	NULL
99	NULL
%	NULL
were	NULL
cultured	NULL
for	NULL
18	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
24-well	NULL
plates	NULL
at	NULL
2	NULL
X	NULL
10°	NULL
cells/ml	NULL
in	NULL
complete	NULL
medium	NULL
(	NULL
RPMI	NULL
1640	NULL
with	NULL
5	NULL
%	NULL
dialyzed	NULL
FBS	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
the	NULL
following	NULL
cytokines	NULL
:	NULL
IL-3	NULL
at	NULL
10~'°	NULL
M	NULL
(	NULL
Genzyme	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
;	NULL
IL-4	NULL
at	NULL
10~°	NULL
M	NULL
(	NULL
Genzyme	NULL
)	NULL
;	NULL
and	NULL
IL-5	NULL
at	NULL
10~°	NULL
M	NULL
(	NULL
Amgen	NULL
Biologicals	NULL
,	NULL
Thousand	NULL
Oaks	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Following	NULL
incubation	NULL
,	NULL
eosinophils	NULL
were	NULL
collected	NULL
and	NULL
mixed	NULL
into	NULL
1	NULL
%	NULL
agar	NULL
in	NULL
1	NULL
%	NULL
X	NULL
PBS	NULL
and	NULL
then	NULL
fixed	NULL
in	NULL
4	NULL
%	NULL
freshly	NULL
prepared	NULL
paraformaldehyde	NULL
,	NULL
processed	NULL
,	NULL
and	NULL
embedded	NULL
in	NULL
paraffin	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Five-micrometer	NULL
sections	NULL
0022-1767/98/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
6122	NULL
IL-4	NULL
REGULATION	NULL
OF	NULL
EOSINOPHIL	NULL
TGF-	NULL
«	NULL
AND	NULL
TGF-B1	NULL
EXPRESSION	NULL
B	NULL
FIGURE	NULL
1	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
IL-3	NULL
,	NULL
IL-5	NULL
,	NULL
and	NULL
IL-4	NULL
on	NULL
the	NULL
level	NULL
of	NULL
TGF-	NULL
«	NULL
expression	NULL
of	NULL
by	NULL
human	NULL
peripheral	NULL
blood	NULL
eosinophils	NULL
demonstrated	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
and	NULL
immunohistochemistry	NULL
.	NULL

A	NULL
,	NULL
C	NULL
,	NULL
£	NULL
,	NULL
and	NULL
G	NULL
are	NULL
light	NULL
microscopy	NULL
photomicrographs	NULL
of	NULL
representative	NULL
fields	NULL
of	NULL
peripheral	NULL
blood	NULL
eosinophils	NULL
(	NULL
99	NULL
%	NULL
pure	NULL
)	NULL
from	NULL
donor	NULL
1	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
IL-3	NULL
,	NULL
IL-5	NULL
and	NULL
IL-4	NULL
.	NULL

The	NULL
sections	NULL
were	NULL
subjected	NULL
to	NULL
in	NULL
situ	NULL
hybridization	NULL
with	NULL
a	NULL
``	NULL
S-labeled	NULL
TGF-	NULL
«	NULL
antisense	NULL
riboprobe	NULL
and	NULL
counterstained	NULL
with	NULL
Giemsa	NULL
.	NULL

The	NULL
eosinophils	NULL
exhibit	NULL
the	NULL
characteristic	NULL
pink	NULL
cytoplasm	NULL
and	NULL
bilobed	NULL
nucleus	NULL
.	NULL

TGF-	NULL
mRNA	NULL
,	NULL
demonstrated	NULL
by	NULL
the	NULL
autoradiographic	NULL
grains	NULL
,	NULL
is	NULL
shown	NULL
to	NULL
be	NULL
expressed	NULL
by	NULL
the	NULL
eosinophils	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cytokines	NULL
(	NULL
A	NULL
)	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
labeling	NULL
is	NULL
increased	NULL
after	NULL
incubation	NULL
with	NULL
IL-3	NULL
and	NULL
IL-5	NULL
(	NULL
C	NULL
and	NULL
£	NULL
)	NULL
and	NULL
decreased	NULL
significantly	NULL
after	NULL
incubation	NULL
with	NULL
IL-4	NULL
(	NULL
G	NULL
)	NULL
.	NULL

B	NULL
,	NULL
D	NULL
,	NULL
F	NULL
,	NULL
and	NULL
H	NULL
,	NULL
Light	NULL
microscopy	NULL
photomicrographs	NULL
of	NULL
sections	NULL
adjacent	NULL
to	NULL
those	NULL
shown	NULL
in	NULL
A	NULL
,	NULL
C	NULL
,	NULL
£	NULL
,	NULL
and	NULL
G	NULL
immunostained	NULL
with	NULL
the	NULL
TGF-	NULL
«	NULL
mAb	NULL
followed	NULL
by	NULL
detection	NULL
using	NULL
an	NULL
alkaline	NULL
phosphatase	NULL
method	NULL
and	NULL
counterstaining	NULL
with	NULL
aniline	NULL
blue	NULL
.	NULL

The	NULL
staining	NULL
demonstrating	NULL
intracellular	NULL
TGF-a	NULL
immunoreactivity	NULL
is	NULL
noted	NULL
in	NULL
eosinophils	NULL
that	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cytokines	NULL
(	NULL
B	NULL
)	NULL
.	NULL

As	NULL
demonstrated	NULL
by	NULL
the	NULL
in	NULL
situ	NULL
hybridization	NULL
results	NULL
,	NULL
the	NULL
intensity	NULL
of	NULL
staining	NULL
appears	NULL
to	NULL
increase	NULL
after	NULL
incubation	NULL
with	NULL
IL-3	NULL
and	NULL
IL-5	NULL
(	NULL
D	NULL
and	NULL
F	NULL
)	NULL
and	NULL
to	NULL
decrease	NULL
significantly	NULL
after	NULL
incubation	NULL
with	NULL
IL-4	NULL
.	NULL

Magnification	NULL
,	NULL
X250	NULL
.	NULL

were	NULL
mounted	NULL
on	NULL
gelatin-coated	NULL
slides	NULL
for	NULL
in	NULL
situ	NULL
hybridization	NULL
and	NULL
immunohistochemistry	NULL
.	NULL

Supernatants	NULL
from	NULL
incubations	NULL
were	NULL
collected	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
for	NULL
ELISA	NULL
analysis	NULL
.	NULL

In	NULL
situ	NULL
hybridization	NULL
Our	NULL
in	NULL
situ	NULL
hybridization	NULL
procedures	NULL
using	NULL
the	NULL
antisense	NULL
and	NULL
sense	NULL
human	NULL
TGE-a	NULL
«	NULL
and	NULL
TGF-B1	NULL
*S-labeled	NULL
riboprobes	NULL
have	NULL
been	NULL
described	NULL
in	NULL
detail	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Immunohistochemistry	NULL
To	NULL
detect	NULL
human	NULL
TGF-	NULL
,	NULL
we	NULL
used	NULL
a	NULL
mAb	NULL
directed	NULL
against	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
the	NULL
human	NULL
TGF-	NULL
mature	NULL
peptide	NULL
(	NULL
amino	NULL
acids	NULL
34-50	NULL
)	NULL
(	NULL
TGF-a	NULL
:	NULL
Ab-2	NULL
;	NULL
GF-10	NULL
;	NULL
Oncogene	NULL
Science	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

A	NULL
mAb	NULL
to	NULL
the	NULL
bacterial	NULL
protein	NULL
was	NULL
used	NULL
at	NULL
the	NULL
same	NULL
concentration	NULL
as	NULL
the	NULL
negative	NULL
control	NULL
.	NULL

To	NULL
detect	NULL
TGF-B1	NULL
,	NULL
we	NULL
used	NULL
a	NULL
rabbit	NULL
anti-human	NULL
TGF-B1	NULL
polyclonal	NULL
Ab	NULL
at	NULL
1:100	NULL
dilution	NULL
(	NULL
AB-20-PB	NULL
;	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

An	NULL
IgG	NULL
fraction	NULL
from	NULL
a	NULL
nonimmune	NULL
normal	NULL
rabbit	NULL
(	NULL
-5006	NULL
;	NULL
Sigma	NULL
Chemical	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
was	NULL
used	NULL
at	NULL
the	NULL
same	NULL
concentration	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

Immunohistochemistry	NULL
was	NULL
performed	NULL
using	NULL
an	NULL
alkaline	NULL
phosphatase	NULL
detection	NULL
system	NULL
.	NULL

All	NULL
sections	NULL
were	NULL
counterstained	NULL
with	NULL
0.4	NULL
%	NULL
aniline	NULL
blue	NULL
(	NULL
CI	NULL
42755	NULL
)	NULL
for	NULL
10	NULL
min	NULL
to	NULL
permit	NULL
identification	NULL
of	NULL
eosinophils	NULL
by	NULL
UV	NULL
fluorescence	NULL
microscopy	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

Quantitative	NULL
analysis	NULL
of	NULL
in	NULL
situ	NULL
hybridization	NULL
data	NULL
In	NULL
situ	NULL
hybridization	NULL
results	NULL
were	NULL
quantified	NULL
using	NULL
a	NULL
computer	NULL
imaging	NULL
analysis	NULL
system	NULL
(	NULL
MetaMorph	NULL
,	NULL
Universal	NULL
Imaging	NULL
,	NULL
West	NULL
Chester	NULL
,	NULL
PA	NULL
)	NULL
.	NULL

Slides	NULL
with	NULL
sections	NULL
of	NULL
eosinophils	NULL
from	NULL
the	NULL
different	NULL
treatment	NULL
conditions	NULL
were	NULL
subjected	NULL
to	NULL
in	NULL
situ	NULL
hybridization	NULL
.	NULL

Following	NULL
autoradiographic	NULL
exposure	NULL
for	NULL
3	NULL
days	NULL
and	NULL
counterstaining	NULL
with	NULL
Giemsa	NULL
,	NULL
slides	NULL
were	NULL
blindly	NULL
coded	NULL
and	NULL
numbered	NULL
in	NULL
random	NULL
order	NULL
.	NULL

Slides	NULL
were	NULL
imaged	NULL
on	NULL
a	NULL
Nikon	NULL
Microphot-FXA	NULL
microscope	NULL
with	NULL
a	NULL
40	NULL
X	NULL
0.95	NULL
objective	NULL
using	NULL
Koehler	NULL
illumination	NULL
.	NULL

Images	NULL
of	NULL
50	NULL
cells	NULL
from	NULL
each	NULL
condition	NULL
were	NULL
acquired	NULL
from	NULL
a	NULL
Sony	NULL
CCD/	NULL
RGB	NULL
color	NULL
video	NULL
camera	NULL
DXC	NULL
151	NULL
.	NULL

Images	NULL
were	NULL
stored	NULL
and	NULL
analyzed	NULL
using	NULL
an	NULL
Universal	NULL
Imaging	NULL
46	NULL
PC	NULL
computer	NULL
running	NULL
the	NULL
MetaMorph	NULL
Imaging	NULL
System	NULL
.	NULL

At	NULL
least	NULL
50	NULL
cells	NULL
were	NULL
quantified	NULL
on	NULL
each	NULL
slide	NULL
.	NULL

Statistical	NULL
analysis	NULL
The	NULL
differences	NULL
between	NULL
the	NULL
experimental	NULL
and	NULL
control	NULL
groups	NULL
was	NULL
analyzed	NULL
by	NULL
Student	NULL
's	NULL
£	NULL
test	NULL
.	NULL

Assessment	NULL
of	NULL
TGF	NULL
protein	NULL
release	NULL
TGF-	NULL
«	NULL
and	NULL
TGF-B1	NULL
proteins	NULL
released	NULL
into	NULL
culture	NULL
supernatants	NULL
were	NULL
assessed	NULL
by	NULL
ELISA	NULL
kits	NULL
from	NULL
Oncogene	NULL
Science	NULL
and	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
respectively	NULL
.	NULL

Each	NULL
sample	NULL
was	NULL
tested	NULL
in	NULL
triplicate	NULL
.	NULL

Flow	NULL
cytometry	NULL
For	NULL
flow	NULL
cytometry	NULL
,	NULL
2	NULL
X	NULL
10°	NULL
purified	NULL
eosinophils	NULL
were	NULL
incubated	NULL
with	NULL
100	NULL
ul	NULL
of	NULL
mouse	NULL
anti-human	NULL
IL-4R	NULL
a-chain	NULL
mAb	NULL
(	NULL
Immunotech	NULL
,	NULL
Westbrook	NULL
,	NULL
ME	NULL
)	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
30	NULL
ug/ml	NULL
(	NULL
diluted	NULL
in	NULL
FACS	NULL
buffer	NULL
(	NULL
HBSS	NULL
without	NULL
Ca/Mg	NULL
+	NULL
0.5	NULL
%	NULL
BSA	NULL
+	NULL
0.1	NULL
%	NULL
azide	NULL
)	NULL
)	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

Isotype	NULL
control	NULL
,	NULL
myeloma	NULL
protein	NULL
(	NULL
MOPC	NULL
21	NULL
)	NULL
,	NULL
was	NULL
used	NULL
at	NULL
the	NULL
same	NULL
concentration	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
twice	NULL
in	NULL
ice-cold	NULL
FACS	NULL
buffer	NULL
and	NULL
resuspended	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
1/32	NULL
dilution	NULL
FITC-conjugated	NULL
goat	NULL
anti-mouse	NULL
(	NULL
Sigma	NULL
Chemi-cal	NULL
)	NULL
.	NULL

After	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
cold	NULL
FACS	NULL
buffer	NULL
and	NULL
fixed	NULL
in	NULL
1	NULL
%	NULL
paraformaldehyde	NULL
.	NULL

FACS	NULL
analysis	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
was	NULL
performed	NULL
on	NULL
at	NULL
least	NULL
10,000	NULL
cells	NULL
.	NULL

Western	NULL
blotting	NULL
Western	NULL
blotting	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
protocol	NULL
of	NULL
Harlow	NULL
and	NULL
Lane	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Cells	NULL
(	NULL
1	NULL
X	NULL
10	NULL
``	NULL
)	NULL
were	NULL
lysed	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
RIPA	NULL
buffer	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMSF	NULL
(	NULL
100	NULL
pg/ml	NULL
!	NULL
)	NULL

and	NULL
aprotinin	NULL
(	NULL
1	NULL
ug/ml	NULL
!	NULL
)	NULL

for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

The	NULL
protein	NULL
content	NULL
of	NULL
each	NULL
lysate	NULL
was	NULL
determined	NULL
by	NULL
a	NULL
Bio-Rad	NULL
(	NULL
Rich-mond	NULL
,	NULL
CA	NULL
)	NULL
DC	NULL
protein	NULL
assay	NULL
.	NULL

The	NULL
rabbit	NULL
polyclonal	NULL
Ab	NULL
to	NULL
STAT6	NULL
was	NULL
obtained	NULL
from	NULL
Transduction	NULL
Laboratories	NULL
(	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
,	NULL
while	NULL
the	NULL
4PS/IRS2	NULL
Ab	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Dr.	NULL
Morris	NULL
White	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
MA	NULL
.	NULL

Signal	NULL
detection	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
Kodak	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
6123	NULL
s	NULL
©	NULL
FIGURE	NULL
2	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
IL-3	NULL
,	NULL
IL-5	NULL
and	NULL
IL-4	NULL
on	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
TGF-B1	NULL
by	NULL
human	NULL
peripheral	NULL
blood	NULL
eosinophils	NULL
demonstrated	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
and	NULL
immunchistochemistry	NULL
.	NULL

A	NULL
,	NULL
C	NULL
,	NULL
£	NULL
,	NULL
and	NULL
G	NULL
,	NULL
Light	NULL
microscopy	NULL
photomicrographs	NULL
of	NULL
representative	NULL
fields	NULL
of	NULL
peripheral	NULL
blood	NULL
eosinophils	NULL
from	NULL
the	NULL
same	NULL
donor	NULL
as	NULL
in	NULL
Figure	NULL
1	NULL
(	NULL
adjacent	NULL
sections	NULL
)	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
IL-3	NULL
,	NULL
IL-5	NULL
,	NULL
and	NULL
IL-4	NULL
.	NULL

The	NULL
sections	NULL
were	NULL
subjected	NULL
to	NULL
in	NULL
situ	NULL
hybridization	NULL
with	NULL
a	NULL
*°S-labeled	NULL
TGF-B1	NULL
antisense	NULL
riboprobe	NULL
and	NULL
counterstained	NULL
with	NULL
Giemsa	NULL
.	NULL

TGF-B1	NULL
mRNA	NULL
,	NULL
demonstrated	NULL
by	NULL
the	NULL
autoradiographic	NULL
grains	NULL
,	NULL
is	NULL
detectable	NULL
in	NULL
one	NULL
of	NULL
the	NULL
two	NULL
cells	NULL
representing	NULL
the	NULL
control	NULL
group	NULL
of	NULL
eosinophils	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cytokines	NULL
(	NULL
A	NULL
)	NULL
.	NULL

The	NULL
intensity	NULL
of	NULL
labeling	NULL
is	NULL
increased	NULL
after	NULL
incubation	NULL
with	NULL
IL-3	NULL
to	NULL
the	NULL
extent	NULL
that	NULL
the	NULL
cells	NULL
are	NULL
completely	NULL
masked	NULL
by	NULL
the	NULL
autoradiographic	NULL
grains	NULL
(	NULL
C	NULL
)	NULL
and	NULL
is	NULL
also	NULL
increased	NULL
after	NULL
incubation	NULL
with	NULL
IL-5	NULL
as	NULL
well	NULL
as	NULL
IL-4	NULL
(	NULL
E	NULL
and	NULL
G	NULL
)	NULL
.	NULL

B	NULL
,	NULL
D	NULL
,	NULL
F	NULL
,	NULL
and	NULL
H	NULL
,	NULL
Light	NULL
microscopy	NULL
photomicrographs	NULL
of	NULL
sections	NULL
adjacent	NULL
to	NULL
those	NULL
shown	NULL
in	NULL
A	NULL
,	NULL
C	NULL
,	NULL
E	NULL
,	NULL
and	NULL
G	NULL
immunostained	NULL
with	NULL
the	NULL
TGF-B1	NULL
polyclonal	NULL
Ab	NULL
followed	NULL
by	NULL
detection	NULL
by	NULL
an	NULL
alkaline	NULL
phosphatase	NULL
method	NULL
and	NULL
counterstained	NULL
with	NULL
aniline	NULL
blue	NULL
.	NULL

The	NULL
staining	NULL
demonstrating	NULL
intracellular	NULL
TGF-B1	NULL
immunoreactivity	NULL
is	NULL
noted	NULL
in	NULL
eosinophils	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cytokines	NULL
(	NULL
B	NULL
)	NULL
.	NULL

As	NULL
demonstrated	NULL
by	NULL
the	NULL
in	NULL
situ	NULL
hybridization	NULL
results	NULL
,	NULL
the	NULL
intensity	NULL
of	NULL
staining	NULL
appears	NULL
to	NULL
significantly	NULL
increase	NULL
after	NULL
incubation	NULL
with	NULL
IL-3	NULL
and	NULL
IL-5	NULL
,	NULL
as	NULL
well	NULL
as	NULL
IL-4	NULL
(	NULL
D	NULL
,	NULL
F	NULL
,	NULL
and	NULL
H	NULL
)	NULL
.	NULL

Magnification	NULL
,	NULL
X250	NULL
.	NULL

Chemiluminescent	NULL
Detection	NULL
System	NULL
and	NULL
BioMax	NULL
MR	NULL
film	NULL
(	NULL
both	NULL
from	NULL
Eastman	NULL
Kodak	NULL
,	NULL
Rochester	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Results	NULL
Constitutive	NULL
expression	NULL
of	NULL
TGF	NULL
mRNA	NULL
by	NULL
peripheral	NULL
blood	NULL
eosinophils	NULL
Since	NULL
our	NULL
initial	NULL
report	NULL
,	NULL
which	NULL
demonstrated	NULL
that	NULL
eosinophils	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
healthy	NULL
donors	NULL
showed	NULL
no	NULL
detectable	NULL
levels	NULL
of	NULL
TGF-a	NULL
or	NULL
TGF-B1	NULL
mRNA	NULL
and	NULL
protein	NULL
,	NULL
we	NULL
have	NULL
modified	NULL
our	NULL
procedure	NULL
for	NULL
eosinophil	NULL
isolation	NULL
by	NULL
adding	NULL
an	NULL
incubation	NULL
step	NULL
with	NULL
anti-CD16	NULL
magnetic	NULL
beads	NULL
to	NULL
achieve	NULL
an	NULL
enriched	NULL
population	NULL
of	NULL
97	NULL
to	NULL
99	NULL
%	NULL
eosinophils	NULL
(	NULL
9	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
in	NULL
situ	NULL
hybridization	NULL
results	NULL
using	NULL
°°S-labeled	NULL
TGF-	NULL
«	NULL
and	NULL
TGF-B1	NULL
antisense	NULL
riboprobes	NULL
showed	NULL
that	NULL
eosinophils	NULL
harvested	NULL
in	NULL
this	NULL
manner	NULL
expressed	NULL
a	NULL
basal	NULL
level	NULL
of	NULL
TGF-	NULL
and	NULL
TGF-B1	NULL
mRNA	NULL
(	NULL
Figs	NULL
.	NULL

14	NULL
and	NULL
2A	NULL
)	NULL
.	NULL

TGF	NULL
mRNA	NULL
expression	NULL
by	NULL
eosinophils	NULL
treated	NULL
with	NULL
IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IL-5	NULL
Marked	NULL
changes	NULL
in	NULL
the	NULL
TGF	NULL
mRNA	NULL
expression	NULL
were	NULL
observed	NULL
in	NULL
peripheral	NULL
blood	NULL
eosinophils	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-3	NULL
,	NULL
-4	NULL
,	NULL
and	NULL
-5	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

To	NULL
quantify	NULL
these	NULL
differences	NULL
,	NULL
a	NULL
computer-assisted	NULL
analysis	NULL
was	NULL
used	NULL
that	NULL
allowed	NULL
us	NULL
to	NULL
quantify	NULL
the	NULL
relative	NULL
changes	NULL
in	NULL
TGF	NULL
mRNA	NULL
levels	NULL
.	NULL

IL-3-	NULL
,	NULL
IL-4-	NULL
,	NULL
and	NULL
IL-5-treated	NULL
eosinophils	NULL
were	NULL
obtained	NULL
from	NULL
six	NULL
normal	NULL
donors	NULL
,	NULL
subjected	NULL
to	NULL
in	NULL
situ	NULL
hybridization	NULL
,	NULL
and	NULL
analyzed	NULL
blindly	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
results	NULL
are	NULL
summarized	NULL
in	NULL
Tables	NULL
I	NULL
and	NULL
II	NULL
.	NULL

All	NULL
of	NULL
the	NULL
cytokines	NULL
used	NULL
significantly	NULL
increased	NULL
TGF-B1	NULL
mRNA	NULL
expression	NULL
in	NULL
all	NULL
of	NULL
the	NULL
donors	NULL
(	NULL
Table	NULL
II	NULL
)	NULL
.	NULL

IL-3	NULL
and	NULL
IL-5	NULL
,	NULL
respectively	NULL
,	NULL
up-regulated	NULL
the	NULL
expression	NULL
of	NULL
TGF-	NULL
«	NULL
mRNA	NULL
in	NULL
five	NULL
of	NULL
the	NULL
six	NULL
donors	NULL
.	NULL

IL-4	NULL
,	NULL
however	NULL
,	NULL
significantly	NULL
down-regulated	NULL
the	NULL
expression	NULL
of	NULL
TGF-a	NULL
in	NULL
all	NULL
six	NULL
donors	NULL
.	NULL

Table	NULL
I	NULL
.	NULL

_	NULL
TGF-o	NULL
mRNA	NULL
expression	NULL
by	NULL
human	NULL
eosinophils	NULL
Donor	NULL
1	NULL
Donor	NULL
2	NULL
Donor	NULL
3	NULL
Donor	NULL
4	NULL
Donor	NULL
5	NULL
Donor	NULL
6	NULL
Control	NULL
1,825	NULL
3,435	NULL
1,950	NULL
2,720	NULL
1,882	NULL
2,142	NULL
IL-3	NULL
18,305***	NULL
4,975	NULL
%	NULL
1,330	NULL
9,428**	NULL
7,904**	NULL
8,140**	NULL
IL-5	NULL
21,266***	NULL
2,165	NULL
2,220	NULL
12,240**	NULL
7,520**	NULL
2,540	NULL
IL-4	NULL
1,025***	NULL
1,375**	NULL
380**	NULL
1,435**	NULL
757**	NULL
664**	NULL
*p	NULL
<	NULL
0.05	NULL
;	NULL
**p	NULL
<	NULL
0.005	NULL
;	NULL
***p	NULL
<	NULL
0.0005	NULL
.	NULL

These	NULL
values	NULL
represent	NULL
the	NULL
areas	NULL
of	NULL
the	NULL
total	NULL
grain	NULL
counts	NULL
of	NULL
50	NULL
cells	NULL
from	NULL
each	NULL
group	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
6124	NULL
IL-4	NULL
REGULATION	NULL
OF	NULL
EOSINOPHIL	NULL
TGF-	NULL
«	NULL
AND	NULL
TGF-B1	NULL
EXPRESSION	NULL
Table	NULL
II	NULL
.	NULL

-	NULL
TGF-BI	NULL
mRNA	NULL
expression	NULL
by	NULL
human	NULL
eosinophils	NULL
Donor	NULL
1	NULL
Donor	NULL
2	NULL
Donor	NULL
3	NULL
Donor	NULL
4	NULL
Donor	NULL
5	NULL
Donor	NULL
6	NULL
Control	NULL
2,325	NULL
3,150	NULL
1,615	NULL
2,247	NULL
3,678	NULL
1,960	NULL
IL-3	NULL
77,327**	NULL
15,850**	NULL
17,805**	NULL
65,198**	NULL
17,556**	NULL
18,970**	NULL
IL-5	NULL
29,567**	NULL
12,250**	NULL
5,1790**	NULL
25,432**	NULL
15,667**	NULL
7,865**	NULL
IL-4	NULL
33,078**	NULL
4,455*	NULL
5,1790**	NULL
42,008**	NULL
45,679**	NULL
38,972**	NULL
*p	NULL
<	NULL
0.005	NULL
;	NULL
**p	NULL
<	NULL
0.0005	NULL
.	NULL

These	NULL
values	NULL
represent	NULL
the	NULL
areas	NULL
of	NULL
the	NULL
total	NULL
grain	NULL
counts	NULL
of	NULL
50	NULL
cells	NULL
from	NULL
each	NULL
group	NULL
.	NULL

TGF	NULL
production	NULL
by	NULL
eosinophils	NULL
treated	NULL
with	NULL
IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IL-5	NULL
Immunohistochemistry	NULL
was	NULL
used	NULL
on	NULL
adjacent	NULL
sections	NULL
to	NULL
evaluate	NULL
intracellular	NULL
immunoreactivity	NULL
for	NULL
TGF-a	NULL
«	NULL
and	NULL
TGF-B1	NULL
.	NULL

Similar	NULL
to	NULL
the	NULL
in	NULL
situ	NULL
hybridization	NULL
results	NULL
,	NULL
eosinophils	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
of	NULL
the	NULL
exogenous	NULL
cytokines	NULL
demonstrated	NULL
a	NULL
basal	NULL
level	NULL
staining	NULL
for	NULL
TGF-a	NULL
and	NULL
TGF-B1	NULL
(	NULL
Figs	NULL
.	NULL

1B	NULL
and	NULL
2B	NULL
)	NULL
.	NULL

Differences	NULL
were	NULL
observed	NULL
in	NULL
the	NULL
intensity	NULL
and	NULL
numbers	NULL
of	NULL
eosinophils	NULL
staining	NULL
for	NULL
both	NULL
TGFs	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
cytokine	NULL
used	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
intensity	NULL
of	NULL
immunoreactivity	NULL
is	NULL
difficult	NULL
to	NULL
quan-tify	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
each	NULL
exogenous	NULL
cytokine	NULL
on	NULL
the	NULL
cellular	NULL
levels	NULL
of	NULL
TGF-	NULL
«	NULL
and	NULL
TGP-B1	NULL
proteins	NULL
were	NULL
quantified	NULL
by	NULL
comparing	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
stained	NULL
for	NULL
TGF-	NULL
«	NULL
and	NULL
TGF-B1	NULL
,	NULL
examining	NULL
100	NULL
cells	NULL
in	NULL
each	NULL
slide	NULL
.	NULL

The	NULL
results	NULL
are	NULL
summarized	NULL
in	NULL
Tables	NULL
III	NULL
and	NULL
IV	NULL
.	NULL

Consistent	NULL
with	NULL
our	NULL
in	NULL
situ	NULL
hybridization	NULL
results	NULL
,	NULL
eosinophils	NULL
incubated	NULL
with	NULL
IL-3	NULL
and	NULL
IL-5	NULL
demonstrated	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
percentages	NULL
of	NULL
cells	NULL
that	NULL
stained	NULL
for	NULL
TGF-B1	NULL
in	NULL
all	NULL
donors	NULL
.	NULL

IL-4-treated	NULL
eosinophils	NULL
demonstrated	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
stained	NULL
for	NULL
TGF-B1	NULL
in	NULL
five	NULL
of	NULL
the	NULL
six	NULL
donors	NULL
.	NULL

Eosinophils	NULL
incubated	NULL
with	NULL
IL-3	NULL
and	NULL
IL-5	NULL
demonstrated	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
number	NULL
of	NULL
cells	NULL
that	NULL
stained	NULL
for	NULL
TGF-a	NULL
;	NULL
however	NULL
,	NULL
eosinophils	NULL
incubated	NULL
with	NULL
IL-4	NULL
consistently	NULL
showed	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
intensities	NULL
of	NULL
staining	NULL
as	NULL
well	NULL
as	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
number	NULL
of	NULL
cells	NULL
that	NULL
stained	NULL
for	NULL
TGF-	NULL
«	NULL
in	NULL
all	NULL
six	NULL
donors	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
IL-4	NULL
increased	NULL
the	NULL
level	NULL
of	NULL
TGF-B1	NULL
protein	NULL
in	NULL
eosinophils	NULL
from	NULL
five	NULL
of	NULL
the	NULL
six	NULL
donors	NULL
,	NULL
while	NULL
it	NULL
consistently	NULL
decreased	NULL
the	NULL
expression	NULL
of	NULL
TGF-a	NULL
protein	NULL
in	NULL
eosinophils	NULL
from	NULL
all	NULL
donors	NULL
examined	NULL
.	NULL

Effect	NULL
of	NULL
IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IL-5	NULL
on	NULL
TGF	NULL
protein	NULL
release	NULL
by	NULL
eosinophils	NULL
Human	NULL
peripheral	NULL
blood	NULL
eosinophils	NULL
from	NULL
three	NULL
donors	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IL-5	NULL
for	NULL
18	NULL
h.	NULL
Cell-free	NULL
supernatants	NULL
from	NULL
these	NULL
cultures	NULL
were	NULL
assayed	NULL
for	NULL
TGF-	NULL
«	NULL
and	NULL
TGF-B1	NULL
protein	NULL
release	NULL
by	NULL
specific	NULL
ELISAs	NULL
.	NULL

The	NULL
results	NULL
demonstrated	NULL
that	NULL
IL-3	NULL
significantly	NULL
enhanced	NULL
TGF-	NULL
«	NULL
release	NULL
by	NULL
eosinophils	NULL
in	NULL
all	NULL
three	NULL
donors	NULL
by	NULL
3.7-	NULL
to	NULL
5.5-fold	NULL
above	NULL
the	NULL
nonstimulated	NULL
controls	NULL
.	NULL

IL-5	NULL
also	NULL
induced	NULL
an	NULL
increase	NULL
in	NULL
TGF-release	NULL
in	NULL
all	NULL
three	NULL
donors	NULL
by	NULL
2.3-	NULL
to	NULL
3-fold	NULL
above	NULL
control	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

IL-4	NULL
treatment	NULL
led	NULL
to	NULL
a	NULL
slight	NULL
decrease	NULL
of	NULL
TGF-	NULL
«	NULL
release	NULL
compared	NULL
to	NULL
nonstimulated	NULL
control	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
IL-4	NULL
and	NULL
IL-5	NULL
on	NULL
TGF-	NULL
«	NULL
release	NULL
by	NULL
the	NULL
treated	NULL
eosinophils	NULL
were	NULL
not	NULL
significant	NULL
.	NULL

Table	NULL
III	NULL
.	NULL

TGF-a	NULL
«	NULL
production	NULL
by	NULL
human	NULL
eosinophils	NULL
(	NULL
%	NULL
)	NULL
``	NULL
IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IL-5	NULL
treatment	NULL
of	NULL
human	NULL
eosinophils	NULL
led	NULL
to	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
TGF-B1	NULL
release	NULL
in	NULL
all	NULL
donors	NULL
examined	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Eosinophils	NULL
express	NULL
IL-4R	NULL
and	NULL
IL-4	NULL
signaling	NULL
proteins	NULL
4PS	NULL
and	NULL
STAT6	NULL
Our	NULL
observations	NULL
demonstrated	NULL
that	NULL
eosinophils	NULL
are	NULL
responsive	NULL
to	NULL
IL-4	NULL
and	NULL
therefore	NULL
should	NULL
express	NULL
cell	NULL
surface	NULL
IL-4R	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
human	NULL
eosinophils	NULL
express	NULL
receptors	NULL
to	NULL
IL-4	NULL
,	NULL
peripheral	NULL
blood	NULL
human	NULL
eosinophils	NULL
were	NULL
phenotyped	NULL
for	NULL
IL-4R	NULL
by	NULL
RT-PCR	NULL
and	NULL
flow	NULL
cytometry	NULL
.	NULL

Figure	NULL
44	NULL
shows	NULL
that	NULL
when	NULL
using	NULL
human	NULL
IL-4R	NULL
PCR	NULL
primers	NULL
(	NULL
Clontech	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
to	NULL
amplify	NULL
total	NULL
RNA	NULL
isolated	NULL
from	NULL
two	NULL
normal	NULL
donors	NULL
,	NULL
the	NULL
expected	NULL
526-bp	NULL
IL-4R	NULL
PCR	NULL
product	NULL
was	NULL
detected	NULL
in	NULL
both	NULL
donors	NULL
.	NULL

For	NULL
flow	NULL
cytometry	NULL
,	NULL
2	NULL
%	NULL
10°	NULL
purified	NULL
eosinophils	NULL
were	NULL
incubated	NULL
with	NULL
mouse	NULL
anti-human	NULL
IL-4R	NULL
a-chain	NULL
mAb	NULL
(	NULL
Immunotech	NULL
)	NULL
.	NULL

Compared	NULL
with	NULL
the	NULL
control	NULL
(	NULL
black	NULL
line	NULL
)	NULL
,	NULL
cells	NULL
stained	NULL
with	NULL
anti-IL-4R	NULL
-chain	NULL
mAb	NULL
showed	NULL
a	NULL
unimodal	NULL
increase	NULL
in	NULL
fluorescence	NULL
,	NULL
indicating	NULL
that	NULL
human	NULL
eosinophils	NULL
constitutively	NULL
express	NULL
IL-4R	NULL
«	NULL
-chain	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Since	NULL
IL-4	NULL
is	NULL
known	NULL
to	NULL
act	NULL
in	NULL
various	NULL
cells	NULL
via	NULL
either	NULL
the	NULL
4PS	NULL
or	NULL
STAT6	NULL
signaling	NULL
pathways	NULL
,	NULL
Western	NULL
blotting	NULL
was	NULL
used	NULL
to	NULL
evaluate	NULL
these	NULL
signal	NULL
transduction	NULL
proteins	NULL
in	NULL
lysates	NULL
from	NULL
peripheral	NULL
blood	NULL
human	NULL
eosinophils	NULL
.	NULL

Figure	NULL
5	NULL
demonstrates	NULL
the	NULL
detection	NULL
of	NULL
STAT6	NULL
and	NULL
4PS	NULL
signaling	NULL
molecules	NULL
in	NULL
normal	NULL
human	NULL
eosinophils	NULL
.	NULL

The	NULL
sizes	NULL
of	NULL
the	NULL
human	NULL
STAT6	NULL
and	NULL
4PS	NULL
proteins	NULL
are	NULL
100	NULL
and	NULL
170	NULL
kDa	NULL
,	NULL
respectively	NULL
.	NULL

Discussion	NULL
We	NULL
and	NULL
others	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
human	NULL
eosinophils	NULL
in	NULL
either	NULL
infiltrating	NULL
tumors	NULL
or	NULL
inflammatory	NULL
disorders	NULL
express	NULL
TGF-	NULL
«	NULL
and	NULL
TGE-B1	NULL
,	NULL
whereas	NULL
eosinophils	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
normal	NULL
donors	NULL
do	NULL
not	NULL
(	NULL
2	NULL
,	NULL
3	NULL
,	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
sequential	NULL
expression	NULL
of	NULL
TGF-a	NULL
@	NULL
followed	NULL
by	NULL
TGF-B1	NULL
by	NULL
eosinophils	NULL
was	NULL
demonstrated	NULL
in	NULL
cutaneous	NULL
wound	NULL
healing	NULL
in	NULL
the	NULL
hamster	NULL
(	NULL
4	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
led	NULL
us	NULL
to	NULL
hypothesize	NULL
that	NULL
biologic	NULL
mediators	NULL
in	NULL
the	NULL
tissue	NULL
can	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
eosinophil-derived	NULL
TGFs	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
in	NULL
this	NULL
paper	NULL
indicate	NULL
that	NULL
IL-3	NULL
and	NULL
IL-5	NULL
can	NULL
stimulate	NULL
the	NULL
expression	NULL
of	NULL
both	NULL
TGF-	NULL
«	NULL
@	NULL
and	NULL
TGF-B1	NULL
by	NULL
normal	NULL
peripheral	NULL
blood	NULL
eosinophils	NULL
,	NULL
whereas	NULL
IL-4	NULL
up-regulates	NULL
eosinophil	NULL
synthesis	NULL
of	NULL
TGF-B1	NULL
but	NULL
suppresses	NULL
TGF-	NULL
«	NULL
expression	NULL
at	NULL
both	NULL
the	NULL
mRNA	NULL
and	NULL
protein	NULL
level	NULL
.	NULL

Table	NULL
IV	NULL
.	NULL

TGF-B1	NULL
production	NULL
by	NULL
human	NULL
eosinophils	NULL
(	NULL
%	NULL
)	NULL
``	NULL
Donor	NULL
1	NULL
Donor	NULL
2	NULL
Donor	NULL
3	NULL
Donor4	NULL
Donor	NULL
5	NULL
Donor	NULL
6	NULL
Donor	NULL
1	NULL
Donor	NULL
2	NULL
Donor	NULL
3	NULL
Donor4	NULL
Donor	NULL
5	NULL
Donor	NULL
6	NULL
Control	NULL
67	NULL
86	NULL
46	NULL
55	NULL
32	NULL
43	NULL
IL-3	NULL
89	NULL
97	NULL
70	NULL
82	NULL
67	NULL
87	NULL
IL-5	NULL
78	NULL
90	NULL
T7	NULL
89	NULL
76	NULL
87	NULL
IL-4	NULL
18	NULL
84	NULL
2	NULL
22	NULL
9	NULL
14	NULL
Control	NULL
67	NULL
78	NULL
0	NULL
43	NULL
36	NULL
57	NULL
IL-3	NULL
83	NULL
100	NULL
45	NULL
82	NULL
76	NULL
65	NULL
IL-5	NULL
89	NULL
100	NULL
82	NULL
75	NULL
82	NULL
88	NULL
IL-4	NULL
43	NULL
100	NULL
35	NULL
67	NULL
83	NULL
78	NULL
``	NULL
Percentages	NULL
of	NULL
eosinophils	NULL
that	NULL
stained	NULL
with	NULL
TGF-a	NULL
Ab	NULL
determined	NULL
by	NULL
counting	NULL
100	NULL
cells	NULL
in	NULL
each	NULL
group	NULL
.	NULL

``	NULL
Percentages	NULL
of	NULL
eosinophils	NULL
that	NULL
stained	NULL
with	NULL
TGF-B1	NULL
Ab	NULL
determined	NULL
by	NULL
counting	NULL
100	NULL
cells	NULL
in	NULL
each	NULL
group	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
119	NULL
*	NULL
100	NULL
90	NULL
80	NULL
70	NULL
60	NULL
50	NULL
I	NULL
40	NULL
30	NULL
Lc	NULL
10	NULL
TGF-	NULL
«	NULL
pg/ml	NULL
Control	NULL
IL-3	NULL
IL-4	NULL
IL-5	NULL
Treatment	NULL
B	NULL
700	NULL
x	NULL
600	NULL
500	NULL
I	NULL
400	NULL
pg/ml	NULL
TGF-	NULL
Bi	NULL
300	NULL
200	NULL
100	NULL
Control	NULL
IL-3	NULL
IL-4	NULL
IL-5	NULL
Treatment	NULL
*	NULL
P	NULL
<	NULL
0.05	NULL
FIGURE	NULL
3	NULL
.	NULL

-	NULL
Effect	NULL
of	NULL
IL-3	NULL
,	NULL
IL-5	NULL
,	NULL
and	NULL
IL-4	NULL
on	NULL
the	NULL
release	NULL
of	NULL
TGF-	NULL
(	NULL
A	NULL
)	NULL
and	NULL
TGF-B1	NULL
(	NULL
B	NULL
)	NULL
proteins	NULL
by	NULL
peripheral	NULL
blood	NULL
eosinophils	NULL
.	NULL

Cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
control	NULL
)	NULL
and	NULL
presence	NULL
of	NULL
IL-3	NULL
(	NULL
10	NULL
'*	NULL
M	NULL
)	NULL
,	NULL
IL-4	NULL
(	NULL
10~°	NULL
M	NULL
)	NULL
,	NULL
and	NULL
IL-5	NULL
(	NULL
10~°	NULL
M	NULL
)	NULL
for	NULL
18	NULL
h.	NULL
Incubation	NULL
media	NULL
were	NULL
analyzed	NULL
for	NULL
TGF-	NULL
«	NULL
and	NULL
TGF-B1	NULL
proteins	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Meth-ods	NULL
;	NULL
results	NULL
are	NULL
given	NULL
as	NULL
means	NULL
+	NULL
SEM	NULL
of	NULL
3	NULL
donors	NULL
(	NULL
*	NULL
indicates	NULL
statistical	NULL
significance	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
number	NULL
of	NULL
eosinophils	NULL
is	NULL
relatively	NULL
small	NULL
in	NULL
the	NULL
circulating	NULL
blood	NULL
,	NULL
it	NULL
is	NULL
often	NULL
a	NULL
challenge	NULL
to	NULL
obtain	NULL
sufficient	NULL
numbers	NULL
of	NULL
purified	NULL
cells	NULL
to	NULL
conduct	NULL
studies	NULL
both	NULL
on	NULL
the	NULL
mRNA	NULL
and	NULL
protein	NULL
M1223	NULL
4	NULL
FIGURE	NULL
4	NULL
.	NULL

Eosinophils	NULL
_	NULL
express	NULL
IL-4	NULL
receptors	NULL
.	NULL

A	NULL
,	NULL
detection	NULL
of	NULL
IL-4R	NULL
mRNA	NULL
in	NULL
two	NULL
normal	NULL
donors	NULL
using	NULL
RT-PCR	NULL
.	NULL

M	NULL
=	NULL
100-bp	NULL
m.w	NULL
.	NULL

marker	NULL
;	NULL
lane	NULL
1	NULL
,	NULL
PBMCs	NULL
(	NULL
positive	NULL
control	NULL
)	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
same	NULL
as	NULL
lane	NULL
1	NULL
omitting	NULL
reverse	NULL
transcriptase	NULL
(	NULL
negative	NULL
control	NULL
)	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
normal	NULL
donor	NULL
1	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
normal	NULL
donor	NULL
2	NULL
.	NULL

The	NULL
size	NULL
of	NULL
the	NULL
expected	NULL
IL-4R	NULL
PCR	NULL
product	NULL
is	NULL
526	NULL
bp	NULL
.	NULL

B	NULL
,	NULL
Flow	NULL
cytometry	NULL
of	NULL
purified	NULL
eosinophils	NULL
incubated	NULL
with	NULL
mouse	NULL
anti-human	NULL
IL-4R	NULL
-chain	NULL
mAb	NULL
.	NULL

<	NULL
-	NULL
IL-4R	NULL
(	NULL
526-bp	NULL
)	NULL
6125	NULL
levels	NULL
.	NULL

To	NULL
overcome	NULL
this	NULL
difficulty	NULL
,	NULL
in	NULL
situ	NULL
techniques	NULL
were	NULL
employed	NULL
enabling	NULL
us	NULL
to	NULL
work	NULL
with	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
and	NULL
facilitating	NULL
specific	NULL
identification	NULL
of	NULL
positive	NULL
cells	NULL
.	NULL

The	NULL
inability	NULL
to	NULL
accurately	NULL
quantify	NULL
the	NULL
immunohistochemical	NULL
staining	NULL
intensities	NULL
precluded	NULL
a	NULL
direct	NULL
comparison	NULL
with	NULL
the	NULL
more	NULL
quantitative	NULL
mRNA	NULL
labeling	NULL
results	NULL
generated	NULL
by	NULL
computer-assisted	NULL
analysis	NULL
.	NULL

Never-theless	NULL
,	NULL
we	NULL
noted	NULL
differences	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
that	NULL
stained	NULL
for	NULL
both	NULL
TGFs	NULL
,	NULL
which	NULL
correlated	NULL
with	NULL
the	NULL
in	NULL
situ	NULL
hybridization	NULL
results	NULL
.	NULL

The	NULL
inhibitory	NULL
effect	NULL
of	NULL
IL-4	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
TGF-	NULL
was	NULL
initially	NULL
shown	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
and	NULL
immunohistochemistry	NULL
,	NULL
later	NULL
confirmed	NULL
by	NULL
TGF-o-specific	NULL
ELISA	NULL
.	NULL

Although	NULL
the	NULL
amount	NULL
of	NULL
TGF-	NULL
«	NULL
released	NULL
by	NULL
the	NULL
IL-4-treated	NULL
eosinophils	NULL
did	NULL
not	NULL
show	NULL
a	NULL
significant	NULL
reduction	NULL
by	NULL
ELISA	NULL
,	NULL
a	NULL
slight	NULL
decrease	NULL
was	NULL
ob-served	NULL
.	NULL

While	NULL
the	NULL
mechanism	NULL
responsible	NULL
for	NULL
this	NULL
apparent	NULL
discrepancy	NULL
is	NULL
not	NULL
clear	NULL
,	NULL
potential	NULL
reasons	NULL
for	NULL
the	NULL
observed	NULL
finding	NULL
include	NULL
the	NULL
sensitivity	NULL
of	NULL
the	NULL
assays	NULL
and	NULL
increased	NULL
stability	NULL
of	NULL
secreted	NULL
TGF-	NULL
protein	NULL
when	NULL
treated	NULL
with	NULL
IL-4	NULL
.	NULL

In	NULL
the	NULL
cytokine-treated	NULL
human	NULL
eosinophils	NULL
,	NULL
IL-4	NULL
consistently	NULL
up-regulated	NULL
expression	NULL
of	NULL
TGF-BIl	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
,	NULL
immunohistochemistry	NULL
,	NULL
and	NULL
ELISA	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
eosinophils	NULL
and	NULL
their	NULL
accumulation	NULL
in	NULL
tissue	NULL
sites	NULL
is	NULL
believed	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
mechanisms	NULL
that	NULL
involve	NULL
T	NULL
cell-derived	NULL
cytokines	NULL
(	NULL
13	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
a	NULL
subset	NULL
of	NULL
helper	NULL
T	NULL
cells	NULL
,	NULL
Th2	NULL
,	NULL
secretes	NULL
IL-5	NULL
,	NULL
which	NULL
like	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
is	NULL
released	NULL
by	NULL
both	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
,	NULL
influences	NULL
eosinophil	NULL
growth	NULL
,	NULL
maturation	NULL
,	NULL
and	NULL
differentiation	NULL
,	NULL
and	NULL
appears	NULL
to	NULL
be	NULL
critical	NULL
in	NULL
prolonging	NULL
the	NULL
survival	NULL
of	NULL
eosinophils	NULL
in	NULL
tissues	NULL
and	NULL
allowing	NULL
their	NULL
movement	NULL
into	NULL
the	NULL
tissues	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Although	NULL
these	NULL
lymphokines	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
eosinophils	NULL
and	NULL
prime	NULL
them	NULL
for	NULL
several	NULL
other	NULL
effector	NULL
functions	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
,	NULL
only	NULL
a	NULL
few	NULL
studies	NULL
have	NULL
evaluated	NULL
the	NULL
effects	NULL
of	NULL
cytokines	NULL
such	NULL
as	NULL
IL-3	NULL
or	NULL
IL-5	NULL
on	NULL
expression	NULL
levels	NULL
of	NULL
eosinophil-derived	NULL
cytokines	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
our	NULL
study	NULL
,	NULL
Brach	NULL
et	NULL
al	NULL
.	NULL

have	NULL
shown	NULL
that	NULL
treatment	NULL
with	NULL
both	NULL
IL-3	NULL
and	NULL
IL-5	NULL
resulted	NULL
in	NULL
a	NULL
sever-alfold	NULL
increase	NULL
of	NULL
TGF-	NULL
mRNA	NULL
expression	NULL
and	NULL
in	NULL
protein	NULL
release	NULL
by	NULL
eosinophils	NULL
(	NULL
17	NULL
)	NULL
.	NULL

IL-4	NULL
,	NULL
originally	NULL
defined	NULL
as	NULL
a	NULL
B	NULL
cell	NULL
growth	NULL
factor	NULL
(	NULL
18	NULL
)	NULL
,	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
a	NULL
pleiotropic	NULL
cytokine	NULL
with	NULL
both	NULL
stimulatory	NULL
as	NULL
well	NULL
as	NULL
inhibitory	NULL
effects	NULL
on	NULL
monocytes	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
mononuclear	NULL
cells	NULL
by	NULL
IL-4	NULL
has	NULL
been	NULL
widely	NULL
studied	NULL
.	NULL

IL-4	NULL
was	NULL
shown	NULL
to	NULL
inhibit	NULL
the	NULL
production	NULL
of	NULL
cytokines	NULL
such	NULL
as	NULL
IL-1	NULL
,	NULL
TNF-a	NULL
,	NULL
and	NULL
IL-6	NULL
,	NULL
but	NULL
to	NULL
enhance	NULL
the	NULL
production	NULL
of	NULL
the	NULL
IL-1	NULL
receptor	NULL
antagonist	NULL
,	NULL
IL-1RA	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Until	NULL
now	NULL
,	NULL
however	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
IL-4	NULL
on	NULL
the	NULL
regulation	NULL
of	NULL
eosinophil-derived	NULL
cytokines	NULL
has	NULL
not	NULL
been	NULL
examined	NULL
.	NULL

IL-4	NULL
may	NULL
indirectly	NULL
effect	NULL
eosinophils	NULL
accumulation	NULL
in	NULL
tissue	NULL
by	NULL
promoting	NULL
the	NULL
adherence	NULL
of	NULL
eosinophils	NULL
but	NULL
not	NULL
neutrophils	NULL
to	NULL
endothelium	NULL
g	NULL
s	NULL
}	NULL
$	NULL
,	NULL
]	NULL
g.	NULL
o	NULL
.	NULL

10°	NULL
10	NULL
)	NULL
102	NULL
10°	NULL
10+	NULL
IL-4R	NULL
FITC	NULL
IL-4R	NULL
a	NULL
chain	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
6126	NULL
IL-4	NULL
REGULATION	NULL
OF	NULL
EOSINOPHIL	NULL
TGF-	NULL
«	NULL
AND	NULL
TGF-B1	NULL
EXPRESSION	NULL
FIGURE	NULL
5	NULL
.	NULL

Detection	NULL
of	NULL
STAT6	NULL
and	NULL
4PS	NULL
signaling	NULL
proteins	NULL
in	NULL
normal	NULL
human	NULL
eosinophils	NULL
by	NULL
western	NULL
blot-ting	NULL
.	NULL

A	NULL
,	NULL
STAT6	NULL
(	NULL
100	NULL
kDa	NULL
)	NULL
in	NULL
eosinophils	NULL
from	NULL
three	NULL
normal	NULL
donors	NULL
.	NULL

B	NULL
,	NULL
4PS	NULL
(	NULL
170	NULL
kDa	NULL
)	NULL
in	NULL
eosinophils	NULL
from	NULL
three	NULL
normal	NULL
donors	NULL
.	NULL

E	NULL
=	NULL
human	NULL
eosinophil	NULL
cell	NULL
line	NULL
EoL-1	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

(	NULL
100-kDa	NULL
)	NULL
(	NULL
20	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
IL-4	NULL
can	NULL
affect	NULL
eosinophils	NULL
directly	NULL
and	NULL
that	NULL
it	NULL
can	NULL
differentially	NULL
regulate	NULL
the	NULL
synthesis	NULL
of	NULL
TGF	NULL
by	NULL
eosinophil	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
theory	NULL
that	NULL
IL-4	NULL
acts	NULL
to	NULL
regulate	NULL
eosinophil	NULL
function	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
by	NULL
RT-PCR	NULL
and	NULL
flow	NULL
cytometry	NULL
that	NULL
normal	NULL
human	NULL
eosinophils	NULL
express	NULL
IL-4R	NULL
.	NULL

Since	NULL
IL-4	NULL
is	NULL
known	NULL
to	NULL
mediate	NULL
its	NULL
pleiotropic	NULL
effects	NULL
on	NULL
cellular	NULL
responses	NULL
via	NULL
4PS	NULL
or	NULL
STAT6	NULL
signal	NULL
pathways	NULL
,	NULL
we	NULL
have	NULL
further	NULL
demonstrated	NULL
the	NULL
presence	NULL
of	NULL
these	NULL
signaling	NULL
proteins	NULL
in	NULL
lysates	NULL
obtained	NULL
from	NULL
peripheral	NULL
blood	NULL
eosinophils	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
recent	NULL
results	NULL
of	NULL
Baskar	NULL
et	NULL
al	NULL
.	NULL

(	NULL
26	NULL
)	NULL
and	NULL
Dubois	NULL
et	NULL
al	NULL
.	NULL

(	NULL
27	NULL
)	NULL
,	NULL
which	NULL
demonstrated	NULL
that	NULL
mature	NULL
eosinophils	NULL
do	NULL
respond	NULL
to	NULL
IL-4	NULL
.	NULL

In	NULL
future	NULL
studies	NULL
,	NULL
we	NULL
plan	NULL
to	NULL
use	NULL
these	NULL
findings	NULL
to	NULL
further	NULL
elucidate	NULL
the	NULL
molecular	NULL
mechanisms	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
TGF	NULL
genes	NULL
expression	NULL
.	NULL

The	NULL
findings	NULL
described	NULL
above	NULL
may	NULL
have	NULL
important	NULL
implications	NULL
in	NULL
the	NULL
context	NULL
of	NULL
our	NULL
in	NULL
vivo	NULL
wound-healing	NULL
studies	NULL
.	NULL

We	NULL
previously	NULL
demonstrated	NULL
a	NULL
wound-healing	NULL
model	NULL
in	NULL
the	NULL
hamster	NULL
in	NULL
which	NULL
eosinophils	NULL
infiltrate	NULL
into	NULL
cutaneous	NULL
healing	NULL
wounds	NULL
and	NULL
elaborate	NULL
both	NULL
TGF-a	NULL
«	NULL
and	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
TGF-	NULL
«	NULL
preceding	NULL
that	NULL
of	NULL
TGE-B1	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
in	NULL
this	NULL
study	NULL
suggest	NULL
that	NULL
IL-4	NULL
may	NULL
act	NULL
as	NULL
an	NULL
in	NULL
situ	NULL
regulator	NULL
of	NULL
TGF	NULL
expression	NULL
by	NULL
eosinophils	NULL
.	NULL

In	NULL
the	NULL
postacute	NULL
phase	NULL
of	NULL
healing	NULL
,	NULL
IL-4	NULL
may	NULL
shut	NULL
off	NULL
TGF-a	NULL
production	NULL
and	NULL
concurrently	NULL
enhance	NULL
TGF-B1	NULL
production	NULL
,	NULL
which	NULL
may	NULL
promote	NULL
extracellular	NULL
remodeling	NULL
and	NULL
inhibit	NULL
epithelial	NULL
proliferation	NULL
.	NULL

Future	NULL
investigations	NULL
will	NULL
be	NULL
aimed	NULL
at	NULL
determining	NULL
whether	NULL
local	NULL
expression	NULL
of	NULL
IL-4	NULL
in	NULL
the	NULL
healing	NULL
wound	NULL
correlates	NULL
with	NULL
the	NULL
switching	NULL
of	NULL
TGF	NULL
expression	NULL
by	NULL
the	NULL
infiltrating	NULL
eosinophils	NULL
.	NULL

In	NULL
support	NULL
of	NULL
IL-4	NULL
as	NULL
a	NULL
facilitator	NULL
of	NULL
wound	NULL
healing	NULL
,	NULL
Kucukcelebi	NULL
et	NULL
al	NULL
.	NULL

reported	NULL
that	NULL
exogenous	NULL
application	NULL
of	NULL
IL-4	NULL
accelerated	NULL
healing	NULL
and	NULL
improved	NULL
the	NULL
breaking	NULL
strength	NULL
of	NULL
a	NULL
wound	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
other	NULL
studies	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
eosinophils	NULL
infiltrating	NULL
hamster	NULL
and	NULL
human	NULL
squamous	NULL
carcinomas	NULL
represent	NULL
a	NULL
source	NULL
of	NULL
TGF-a	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
its	NULL
mitogenic	NULL
effect	NULL
on	NULL
epithelial	NULL
cells	NULL
and	NULL
its	NULL
implication	NULL
in	NULL
malignant	NULL
transformation	NULL
,	NULL
TGF-a	NULL
«	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
potent	NULL
angiogenic	NULL
factor	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Since	NULL
eosinophils	NULL
can	NULL
express	NULL
the	NULL
inhibitory	NULL
cytokine	NULL
TGF-B1	NULL
as	NULL
well	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
in	NULL
situ	NULL
mediators	NULL
such	NULL
as	NULL
IL-4	NULL
can	NULL
induce	NULL
eosinophils	NULL
to	NULL
produce	NULL
TGF-B1	NULL
and	NULL
not	NULL
TGF-	NULL
«	NULL
,	NULL
leading	NULL
to	NULL
inhibition	NULL
of	NULL
tumor	NULL
cell	NULL
growth	NULL
.	NULL

This	NULL
hypothesis	NULL
is	NULL
interesting	NULL
in	NULL
light	NULL
of	NULL
recent	NULL
reports	NULL
by	NULL
Tepper	NULL
et	NULL
al	NULL
.	NULL

(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
describing	NULL
an	NULL
eosinophil-dependent	NULL
mechanism	NULL
for	NULL
the	NULL
anti-tumor	NULL
effect	NULL
of	NULL
IL-4	NULL
(	NULL
24	NULL
)	NULL
.	NULL

In	NULL
recent	NULL
years	NULL
,	NULL
eosinophils	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
synthesize	NULL
a	NULL
wide	NULL
array	NULL
of	NULL
cytokines	NULL
,	NULL
suggesting	NULL
a	NULL
functional	NULL
versatility	NULL
of	NULL
these	NULL
granulocytes	NULL
.	NULL

Little	NULL
is	NULL
known	NULL
,	NULL
however	NULL
,	NULL
about	NULL
the	NULL
control	NULL
and	NULL
regulation	NULL
of	NULL
eosinophil-derived	NULL
cytokine	NULL
production	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
IL-4	NULL
can	NULL
simultaneously	NULL
up-regulate	NULL
the	NULL
synthesis	NULL
of	NULL
TGF-B1	NULL
and	NULL
inhibit	NULL
the	NULL
synthesis	NULL
of	NULL
eosinophil-derived	NULL
stats	NULL
-a	NULL
a	NULL
E	NULL
-	NULL
N1	NULL
N2	NULL
N3	NULL
E	NULL
-	NULL
N1	NULL
N2	NULL
N3	NULL
kDa	NULL
-	NULL
244	NULL
&	NULL
-	NULL
@	NULL
@	NULL
w®	NULL
--	NULL
-	NULL
139	NULL
-	NULL
(	NULL
170-kDa	NULL
)	NULL
80	NULL
=	NULL
42	NULL
e	NULL
-	NULL
-	NULL
320-0	NULL
®	NULL
<	NULL
l	NULL
--	NULL
--	NULL
-i	NULL
fm	NULL
TGF-	NULL
«	NULL
,	NULL
implying	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
cytokines	NULL
by	NULL
eosinophils	NULL
can	NULL
be	NULL
differentially	NULL
regulated	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
TGFs	NULL
by	NULL
eosinophils	NULL
may	NULL
be	NULL
modulated	NULL
in	NULL
a	NULL
selective	NULL
manner	NULL
by	NULL
particular	NULL
cytokines	NULL
present	NULL
in	NULL
the	NULL
microenvironment	NULL
of	NULL
various	NULL
pathologic	NULL
and	NULL
physiologic	NULL
processes	NULL
,	NULL
which	NULL
may	NULL
significantly	NULL
affect	NULL
eosinophil	NULL
function	NULL
in	NULL
vivo	NULL
(	NULL
25	NULL
)	NULL
.	NULL

A	NULL
better	NULL
understanding	NULL
of	NULL
TGF	NULL
regulation	NULL
by	NULL
these	NULL
cells	NULL
may	NULL
have	NULL
therapeutic	NULL
implications	NULL
for	NULL
processes	NULL
involving	NULL
eosinophils	NULL
such	NULL
as	NULL
wound	NULL
healing	NULL
,	NULL
carcinogenesis	NULL
,	NULL
and	NULL
allergic	NULL
inflammation	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Dr.	NULL
George	NULL
McNamara	NULL
from	NULL
Universal	NULL
Imaging	NULL
Corp.	NULL
for	NULL
his	NULL
invaluable	NULL
assistance	NULL
with	NULL
the	NULL
computer	NULL
imaging	NULL
analysis	NULL
system	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Elovic	NULL
,	NULL
A.	NULL
,	NULL
S.	NULL
J.	NULL
Galli	NULL
,	NULL
P.	NULL
F.	NULL
Weller	NULL
,	NULL
A.	NULL
L.	NULL
Chang	NULL
,	NULL
T.	NULL
Chiang	NULL
,	NULL
M.	NULL
Y.	NULL
Chou	NULL
,	NULL
R.	NULL
B.	NULL
Donoff	NULL
,	NULL
G.	NULL
T.	NULL
Gallagher	NULL
,	NULL
K.	NULL
Matossian	NULL
,	NULL
J.	NULL
McBride	NULL
,	NULL
M.	NULL
Tsai	NULL
,	NULL
R.	NULL
Todd	NULL
,	NULL
and	NULL
D.	NULL
T.	NULL
W.	NULL
Wong	NULL
.	NULL

1990	NULL
.	NULL

Production	NULL
of	NULL
transforming	NULL
growth	NULL
factor	NULL
alpha	NULL
by	NULL
hamster	NULL
eosinophils	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

137:1425	NULL
.	NULL

2	NULL
.	NULL

Wong	NULL
,	NULL
D.	NULL
T.	NULL
W.	NULL
,	NULL
P.	NULL
F.	NULL
Weller	NULL
,	NULL
S.	NULL
J.	NULL
Galli	NULL
,	NULL
A.	NULL
Elovic	NULL
,	NULL
T.	NULL
H.	NULL
Rand	NULL
,	NULL
G.	NULL
T.	NULL
Gallagher	NULL
,	NULL
T.	NULL
Chiang	NULL
,	NULL
M.	NULL
Y.	NULL
Chou	NULL
,	NULL
K.	NULL
Matossian	NULL
,	NULL
J.	NULL
McBride	NULL
,	NULL
M.	NULL
Tsai	NULL
,	NULL
and	NULL
R.	NULL
Todd	NULL
.	NULL

1990	NULL
.	NULL

Human	NULL
eosinophils	NULL
express	NULL
transforming	NULL
growth	NULL
factor	NULL
alpha	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172	NULL
:	NULL
673	NULL
.	NULL

3	NULL
.	NULL

Wong	NULL
,	NULL
D.	NULL
T.	NULL
W.	NULL
,	NULL
A.	NULL
Elovic	NULL
,	NULL
K.	NULL
Matossian	NULL
,	NULL
N.	NULL
Nagura	NULL
,	NULL
J.	NULL
McBride	NULL
,	NULL
M.	NULL
Y.	NULL
Chou	NULL
,	NULL
J.	NULL
R.	NULL
Gordon	NULL
,	NULL
T.	NULL
H.	NULL
Rand	NULL
,	NULL
S.	NULL
J.	NULL
Galli	NULL
,	NULL
and	NULL
P.	NULL
F.	NULL
Weller	NULL
.	NULL

1991	NULL
.	NULL

Eosinophils	NULL
from	NULL
patients	NULL
with	NULL
blood	NULL
eosinophilia	NULL
express	NULL
transforming	NULL
growth	NULL
factor	NULL
B1	NULL
.	NULL

Blood	NULL
78:2702	NULL
.	NULL

4	NULL
.	NULL

Wong	NULL
,	NULL
D.	NULL
T.	NULL
W.	NULL
,	NULL
R.	NULL
B.	NULL
Donoff	NULL
,	NULL
J.	NULL
Yang	NULL
,	NULL
B.-Z	NULL
.	NULL

Song	NULL
,	NULL
K.	NULL
Matossian	NULL
,	NULL
N.	NULL
Nagura	NULL
,	NULL
A.	NULL
Elovic	NULL
,	NULL
J.	NULL
McBride	NULL
,	NULL
G.	NULL
T.	NULL
Gallagher	NULL
,	NULL
R.	NULL
Todd	NULL
,	NULL
T.	NULL
Chiang	NULL
,	NULL
L.	NULL
S.-S.	NULL
Chou	NULL
,	NULL
M.	NULL
Y.	NULL
Chou	NULL
,	NULL
S.	NULL
J.	NULL
Galli	NULL
,	NULL
and	NULL
P.	NULL
F.	NULL
Weller	NULL
.	NULL

1993	NULL
.	NULL

Sequential	NULL
expression	NULL
of	NULL
TGF-	NULL
@	NULL
and	NULL
TGE-B1	NULL
by	NULL
cosinophils	NULL
during	NULL
cutaneous	NULL
wound	NULL
healing	NULL
in	NULL
the	NULL
hamster	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

143:130	NULL
.	NULL

5	NULL
.	NULL

Barrandon	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
H.	NULL
Green	NULL
.	NULL

1987	NULL
.	NULL

Cell	NULL
migration	NULL
is	NULL
essential	NULL
for	NULL
sustained	NULL
growth	NULL
of	NULL
keratinocytes	NULL
colonies	NULL
:	NULL
the	NULL
role	NULL
of	NULL
transforming	NULL
growth	NULL
factor-	NULL
@	NULL
and	NULL
epidermal	NULL
growth	NULL
factor	NULL
.	NULL

Cell	NULL
50:1131	NULL
.	NULL

6	NULL
.	NULL

Bernard	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
M.	NULL
L.	NULL
Russette	NULL
,	NULL
and	NULL
H.	NULL
L.	NULL
Moses	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
cell	NULL
biology	NULL
of	NULL
transforming	NULL
growth	NULL
factor	NULL
B.	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1032:79	NULL
.	NULL

7	NULL
.	NULL

Kebrl	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
L.	NULL
M.	NULL
Wakefield	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Roberts	NULL
,	NULL
S.	NULL
Jakowlew	NULL
,	NULL
M.	NULL
M.	NULL
Alvarez	NULL
,	NULL
R.	NULL
Derynck	NULL
,	NULL
M.	NULL
B.	NULL
Sporn	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1986	NULL
.	NULL

Production	NULL
of	NULL
transforming	NULL
growth	NULL
factor	NULL
beta	NULL
by	NULL
human	NULL
T	NULL
lymphocytes	NULL
and	NULL
its	NULL
potential	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
T	NULL
cell	NULL
growth	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

163:1037	NULL
.	NULL

8	NULL
.	NULL

Schreiber	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
,	NULL
M.	NULL
E.	NULL
Winkler	NULL
,	NULL
and	NULL
R.	NULL
Derynck	NULL
.	NULL

1986	NULL
.	NULL

Transforming	NULL
growth	NULL
factor-a	NULL
:	NULL
a	NULL
more	NULL
potent	NULL
angiogenic	NULL
mediator	NULL
than	NULL
epidermal	NULL
growth	NULL
factor	NULL
.	NULL

Science	NULL
232:1250	NULL
.	NULL

9	NULL
.	NULL

Lim	NULL
,	NULL
K.	NULL
G.	NULL
,	NULL
and	NULL
P.	NULL
F.	NULL
Weller	NULL
.	NULL

1996	NULL
.	NULL

Isolation	NULL
of	NULL
human	NULL
eosinophils	NULL
.	NULL

In	NULL
Current	NULL
Protocols	NULL
in	NULL
Immunology	NULL
,	NULL
Vol	NULL
.	NULL

2	NULL
.	NULL

J.	NULL
E.	NULL
Coligan	NULL
,	NULL
A.	NULL
M.	NULL
Kruisbeck	NULL
,	NULL
D.	NULL
H.	NULL
Margulies	NULL
,	NULL
E.	NULL
M.	NULL
Shevach	NULL
,	NULL
and	NULL
W.	NULL
Strober	NULL
,	NULL
eds	NULL
.	NULL

John	NULL
Wiley	NULL
&	NULL
Sons	NULL
,	NULL
New	NULL
York	NULL
,	NULL
p.	NULL
7.31.1	NULL
.	NULL

10	NULL
.	NULL

Harlow	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
D.	NULL
Lane	NULL
.	NULL

1988	NULL
.	NULL

Immunoprecipitation	NULL
.	NULL

In	NULL
Antibodies	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

E.	NULL
Harlow	NULL
and	NULL
D.	NULL
Lane	NULL
,	NULL
eds	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
,	NULL
pp	NULL
.	NULL

421-470	NULL
.	NULL

11	NULL
.	NULL

Elovic	NULL
,	NULL
A.	NULL
,	NULL
D.	NULL
T.	NULL
W.	NULL
Wong	NULL
,	NULL
P.	NULL
F.	NULL
Weller	NULL
,	NULL
K.	NULL
Matossian	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Galli	NULL
.	NULL

1994	NULL
.	NULL

Expression	NULL
of	NULL
TGF-a	NULL
and	NULL
TGF-B1	NULL
mRNA	NULL
and	NULL
product	NULL
by	NULL
eosinophils	NULL
in	NULL
nasal	NULL
polyps	NULL
.	NULL

J	NULL
.	NULL

Allergy	NULL
Clin	NULL
.	NULL

Immunol	NULL
.	NULL

93:864	NULL
.	NULL

12	NULL
.	NULL

Ohno	NULL
,	NULL
L.	NULL
,	NULL
R.	NULL
G.	NULL
Lea	NULL
,	NULL
K.	NULL
C.	NULL
Flanders	NULL
,	NULL
D.	NULL
A.	NULL
Clark	NULL
,	NULL
D.	NULL
Banwatt	NULL
,	NULL
J.	NULL
Dolovich	NULL
,	NULL
J.	NULL
Denburg	NULL
,	NULL
C.	NULL
B.	NULL
Harley	NULL
,	NULL
J.	NULL
Gauldie	NULL
,	NULL
and	NULL
M.	NULL
Jordana	NULL
.	NULL

1992	NULL
.	NULL

Eosinophils	NULL
in	NULL
chronically	NULL
inflamed	NULL
human	NULL
upper	NULL
airway	NULL
tissues	NULL
express	NULL
transforming	NULL
growth	NULL
factor	NULL
B1	NULL
gene	NULL
(	NULL
TGFB1	NULL
)	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

89:1662	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

Corrigan	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Kay	NULL
.	NULL

1992	NULL
.	NULL

T	NULL
cells	NULL
and	NULL
eosinophils	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
asthma	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
13:501	NULL
.	NULL

Del	NULL
Prete	NULL
,	NULL
G.	NULL
,	NULL
E.	NULL
Maggi	NULL
,	NULL
and	NULL
S.	NULL
Romagnani	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
:	NULL
functional	NULL
properties	NULL
,	NULL
mechanisms	NULL
of	NULL
regulation	NULL
,	NULL
and	NULL
role	NULL
in	NULL
disease	NULL
.	NULL

Lab	NULL
invest	NULL
.	NULL

70:299	NULL
.	NULL

Silberstein	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
David	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
human	NULL
eosinophil	NULL
function	NULL
by	NULL
cytokines	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
8:380	NULL
.	NULL

Valerius	NULL
,	NULL
T.	NULL
,	NULL
R.	NULL
Repp	NULL
,	NULL
J.	NULL
R.	NULL
Kalden	NULL
,	NULL
and	NULL
E.	NULL
Platzer	NULL
.	NULL

1990	NULL
.	NULL

Effects	NULL
of	NULL
interferon	NULL
on	NULL
human	NULL
eosinophils	NULL
in	NULL
comparison	NULL
with	NULL
other	NULL
cytokines	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

145:2950	NULL
.	NULL

Brach	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
C.	NULL
Sott	NULL
,	NULL
M.	NULL
Kichntopf	NULL
,	NULL
and	NULL
F.	NULL
Herrmann	NULL
.	NULL

1994	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
transforming	NULL
growth	NULL
factor-a	NULL
gene	NULL
by	NULL
human	NULL
eosinophils	NULL
is	NULL
regulated	NULL
by	NULL
inter-leukin-3	NULL
,	NULL
interleukin-5	NULL
,	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

24:646	NULL
.	NULL

Howard	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Farrar	NULL
,	NULL
M.	NULL
Hilfiker	NULL
,	NULL
B.	NULL
Johnson	NULL
,	NULL
K.	NULL
Takatsu	NULL
,	NULL
T.	NULL
Hamaoka	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1982	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
T-cell-derived	NULL
B	NULL
cell	NULL
growth	NULL
factor	NULL
distinct	NULL
from	NULL
interleukin-2	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

155:914	NULL
.	NULL

D'Andrea	NULL
,	NULL
A.	NULL
,	NULL
X.	NULL
Ma	NULL
,	NULL
M.	NULL
Aste-Amezaga	NULL
,	NULL
C.	NULL
Paganin	NULL
,	NULL
and	NULL
G.	NULL
Trinchieri	NULL
.	NULL

1995	NULL
.	NULL

Stimulatory	NULL
and	NULL
Inhibitory	NULL
effects	NULL
of	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-4	NULL
and	NULL
IL-13	NULL
on	NULL
the	NULL
production	NULL
of	NULL
cytokines	NULL
by	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
:	NULL
priming	NULL
for	NULL
TL-12	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
production	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181	NULL
:	NULL
:537	NULL
.	NULL

Moser	NULL
,	NULL
R.	NULL
,	NULL
J.	NULL
Fehr	NULL
,	NULL
and	NULL
P.	NULL
L.	NULL
B.	NULL
Bruijnzeel	NULL
.	NULL

1992	NULL
.	NULL

IL-4	NULL
controls	NULL
the	NULL
selective	NULL
21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

6127	NULL
endothelium-driven	NULL
transmigration	NULL
of	NULL
eosinophils	NULL
from	NULL
allergic	NULL
individuals	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:1432	NULL
.	NULL

Kucukcelebi	NULL
,	NULL
A.	NULL
,	NULL
R.	NULL
H.	NULL
C.	NULL
Harries	NULL
,	NULL
P.	NULL
J.	NULL
Hennessey	NULL
,	NULL
L.	NULL
J.	NULL
Phillips	NULL
,	NULL
L.	NULL
D.	NULL
Brocmeling	NULL
,	NULL
D.	NULL
Listengarten	NULL
,	NULL
F.	NULL
Ko	NULL
,	NULL
S.	NULL
Narula	NULL
,	NULL
and	NULL
M.	NULL
C.	NULL
Robson	NULL
.	NULL

1995	NULL
.	NULL

In	NULL
vivo	NULL
characterization	NULL
of	NULL
interleukin-4	NULL
potential	NULL
wound	NULL
healing	NULL
agent	NULL
.	NULL

Wound	NULL
Repair	NULL
Reg	NULL
.	NULL

3:49	NULL
.	NULL

Tepper	NULL
,	NULL
R.	NULL
I.	NULL
,	NULL
P.	NULL
K.	NULL
Pattengale	NULL
,	NULL
and	NULL
P.	NULL
Leder	NULL
.	NULL

1989	NULL
.	NULL

Murine	NULL
Interleukin-4	NULL
displays	NULL
potent	NULL
anti-tumor	NULL
activity	NULL
in	NULL
vivo	NULL
.	NULL

Cell	NULL
57:503	NULL
.	NULL

Tepper	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
R.	NULL
L.	NULL
Coffman	NULL
,	NULL
and	NULL
P.	NULL
Leder	NULL
.	NULL

1992	NULL
.	NULL

An	NULL
cosinophil-dependent	NULL
mechanism	NULL
for	NULL
the	NULL
antitumor	NULL
effect	NULL
of	NULL
interleukin-4	NULL
.	NULL

Science	NULL
257:548	NULL
.	NULL

Kuger-Krasagakes	NULL
,	NULL
S.	NULL
,	NULL
W.	NULL
Li	NULL
,	NULL
G.	NULL
Richter	NULL
,	NULL
T.	NULL
Diamantstein	NULL
,	NULL
and	NULL
T.	NULL
Blankenstein	NULL
.	NULL

1993	NULL
.	NULL

Eosinophils	NULL
infiltrating	NULL
interleukin-5	NULL
gene-transfected	NULL
tumors	NULL
do	NULL
not	NULL
suppress	NULL
tumor	NULL
growth	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

23:992	NULL
.	NULL

Mogbel	NULL
,	NULL
R.	NULL
,	NULL
F.	NULL
Levi-Schaffer	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Kay	NULL
.	NULL

1994	NULL
.	NULL

Cytokine	NULL
generation	NULL
by	NULL
eosinophils	NULL
.	NULL

J	NULL
.	NULL

Allergy	NULL
Clin	NULL
.	NULL

Immunol	NULL
.	NULL

94:1183	NULL
.	NULL

Baskar	NULL
,	NULL
P.	NULL
,	NULL
D.	NULL
S.	NULL
Silberstein	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Pincus	NULL
.	NULL

1990	NULL
.	NULL

Inhibition	NULL
of	NULL
IgG-triggered	NULL
human	NULL
eosinophil	NULL
function	NULL
by	NULL
IL-4	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:2321	NULL
.	NULL

Dubois	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
C.	NULL
A.	NULL
Bruijnzeel-Koomen	NULL
,	NULL
and	NULL
P.	NULL
L.	NULL
Bruijnzeel	NULL
.	NULL

1994	NULL
.	NULL

IL-4	NULL
induces	NULL
chemotaxis	NULL
of	NULL
blood	NULL
eosinophils	NULL
from	NULL
atopic	NULL
dermatitis	NULL
patients	NULL
,	NULL
but	NULL
not	NULL
from	NULL
normal	NULL
individuals	NULL
.	NULL

J	NULL
.	NULL

Invest	NULL
.	NULL

Dermatol	NULL
.	NULL

102:843	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
810	NULL
wor	NULL
;	NULL

